MedPath

山西天致药业有限公司

Ownership
-
Established
2003-01-24
Employees
-
Market Cap
-
Website
www.cqtzyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

80

NMPA:80

Drug Approvals

Tiopronin Tablets

Product Name
硫普罗宁片
Approval Number
国药准字H20093445
Approval Date
May 22, 2024
NMPA

TABELLAE AMINOPHENAZONIET PHENACETINI COMPOSITAE

Product Name
去痛片
Approval Number
国药准字H14021601
Approval Date
May 22, 2024
NMPA

Compound Vitamin B Tablets

Product Name
复合维生素B片
Approval Number
国药准字H14021599
Approval Date
May 22, 2024
NMPA

Levofloxacin Hydrochloride Capsules

Product Name
盐酸左氧氟沙星胶囊
Approval Number
国药准字H20064563
Approval Date
Jun 11, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H14021676
Approval Date
Aug 13, 2020
NMPA

Diazepam Tablets

Product Name
地西泮片
Approval Number
国药准字H14021670
Approval Date
Aug 13, 2020
NMPA

Chlorpromazine Hydrochloride Tablets

Product Name
盐酸氯丙嗪片
Approval Number
国药准字H14021692
Approval Date
Aug 13, 2020
NMPA

Metronidazole Gargle

Product Name
甲硝唑含漱液
Approval Number
国药准字H10950356
Approval Date
Aug 13, 2020
NMPA

Moroxydine Hydrochloride Tablets

Product Name
盐酸吗啉胍片
Approval Number
国药准字H14023862
Approval Date
Aug 13, 2020
NMPA

Compound Sodium Chloride Injection

Product Name
复方氯化钠注射液
Approval Number
国药准字H14021671
Approval Date
Aug 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.